SWM
TCRT icon

Sugarloaf Wealth Management’s Alaunos Therapeutics TCRT Stock Holding History

Sugarloaf Wealth Management’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$322 Sell
169
-266
-61% -$591 ﹤0.01% 669
2024
Q3 		$1.4K Sell
435
-2
-0.5% -$7 ﹤0.01% 626
2024
Q2 		$3.05K Hold
437
– – ﹤0.01% 561
2024
Q1 		$7.9K Hold
437
– – ﹤0.01% 504
2023
Q4 		$4.63K Sell
437
-66
-13% -$795 ﹤0.01% 553
2023
Q3 		$9.95K Hold
503
– – ﹤0.01% 468
2023
Q2 		$38.5K Hold
503
– – 0.01% 320
2023
Q1 		$47.6K Buy
503
+33
+7% +$3.14K 0.01% 298
2022
Q4 		$45.8K Sell
470
-57
-11% -$8.26K 0.01% 299
2022
Q3 		$136K Buy
527
+17
+3% +$4.94K 0.03% 161
2022
Q2 		$95K Buy
+510
New +$48.7K 0.02% 194
2022
Q1 		– Sell
-427
Closed -$70K – 758
2021
Q4 		$70K Buy
427
+199
+87% +$43.7K 0.02% 243
2021
Q3 		$62K Hold
228
– – 0.02% 247
2021
Q2 		$90K Buy
228
+66
+41% +$30.8K 0.02% 202
2021
Q1 		$87 Hold
162
– – 0.03% 206
2020
Q4 		$61K Hold
162
– – 0.02% 235
2020
Q3 		$61K Hold
162
– – 0.02% 210
2020
Q2 		$80K Hold
162
– – 0.03% 182
2020
Q1 		$59K Hold
162
– – 0.03% 207
2019
Q4 		$114K Buy
+162
New +$111K 0.05% 163

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Sugarloaf Wealth Management's TCRT Position: Q4 2024 in Review

Sugarloaf Wealth Management reduced its Alaunos Therapeutics (TCRT) stake by 61% in Q4 2024, selling an estimated $591 and leaving 169 shares worth $322. The position accounts for ﹤0.01% of the portfolio, ranked #669.

Sugarloaf Wealth Management first reported a position in TCRT in Q4 2019 and has held it in 20 quarters since. The position peaked at $136K in Q3 2022. 30 funds tracked by Wall St. Rank hold TCRT as of Q4 2024.

  • Sugarloaf Wealth Management held 169 shares of Alaunos Therapeutics worth $322 as of Q4 2024.
  • Sugarloaf Wealth Management sold 266 Alaunos Therapeutics shares in Q4 2024, an estimated $591.
  • Alaunos Therapeutics made up ﹤0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #669 holding.
  • Sugarloaf Wealth Management first reported a position in Alaunos Therapeutics in Q4 2019 and has held it in 20 quarters since.
  • Sugarloaf Wealth Management's Alaunos Therapeutics position peaked at $136K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.